Lexie B3 vs Otofonix Encore

The Lexie B3 is a behind-the-ear OTC hearing aid priced at $999 that earns an A grade with a SoundScore of 4.8/5 in our lab testing. This places it at #1 among the 65 OTC hearing aids we've evaluated, making it a standout performer in its category. In our standardized testing, the Lexie B3 demonstrates excellent speech-in-quiet performance at 4.5/5, scoring 1.73 points above the OTC category average of 2.79/5. Speech-in-noise results are more nuanced—while the 2.5/5 score sits 1.02 points above the category average of 1.48/5, this remains mixed in absolute terms. Music streaming quality is solid at 3.3/5, exceeding the category average by 1.38 points, and feedback handling is excellent at 4.6/5. Own-voice comfort scores a solid 3.0/5, sitting 0.49 points above the category average. The device uses a tulip dome coupling in both initial and tuned configurations, maintaining consistent performance across fitting conditions with identical normalized scores of 4.8/5 for both fits. For those considering alternatives, devices like the RxEars Rxi, Meta Ray-Ban Glasses (Gen 2), and Cearvol Wave offer lower price points, though with correspondingly lower SoundScores. The Lexie B3 is best suited for consumers seeking top-tier OTC sound performance who prioritize speech clarity in quieter environments and quality music streaming, and who can accommodate its mid-tier OTC price point.

The Otofonix Encore is a behind-the-ear prescription hearing aid priced at $295, placing it in the budget tier of the prescription category. In our lab testing, it earned a C grade with a SoundScore of 2.7/5, ranking 35th out of 36 prescription hearing aids tested. Sound performance presents significant challenges across most metrics. Speech clarity scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.32 and 0.96 points below category averages respectively. Music streaming capability is essentially absent at 0.0/5, and own-voice comfort is notably limited at 0.1/5 in the tuned configuration—2.65 points below the category average. The one bright spot is feedback handling, which scores an excellent 4.7/5. While this falls just 0.01 points below the category average, it represents strong absolute performance that should minimize whistling issues during daily use. This device runs on disposable batteries. At this price point, shoppers should be aware that the RxEars Rxi offers substantially better sound performance (4.09/5) in the same price range. The Otofonix Encore may suit budget-conscious consumers who prioritize feedback stability over speech clarity and streaming features, but our testing suggests most users would benefit from considering higher-performing alternatives within this price tier.